CABENUVA
First approved long-acting injectable for HIV by Bob Kronemyer The first injectable and complete regimen for HIV-infected adults was approved in January by the Food and Drug Administration (FDA). Cabenuva (ViiV Healthcare and Janssen Pharmaceutica) is a combination of cabotegravir, an HIV integrase strand transfer inhibitor (INSTI), and rilpivirine, a non-nucleoside reverse transcriptase inhibitor (NNRTI), […]